Blue Owl Capital

Investment firm

Blue Owl Capital

Private equity, Venture debt

WebsiteLinkedIn pageCrunchbase profileNew York·United States10known portfolio companies43people tracked20co-investors

Blue Owl Capital is a private equity firm and venture debt provider. Based in New York, United States. Known portfolio companies include Mirador Therapeutics, Pyxis Oncology, Vestwell, BridgeBio, Obsidian Therapeutics and RLDatix, 10 companies in all.

Is Blue Owl Capital a fit for your startup?

Paste your website. AI checks the fit and scores every other investor too.

Investment focus

Contacts

inq***@***.comAvailable after registration.
Get contact

Who to pitch at Blue Owl Capital

Blue Owl Capital portfolio companies (10)

  • Mirador Therapeutics
  • Pyxis Oncology
  • Vestwell
  • BridgeBio
  • Obsidian Therapeutics
  • RLDatix
  • enGene
  • Alterome Therapeutics
  • Monotype
  • XOMA

Co-investors

Funds that share portfolio companies with Blue Owl Capital.

Similar funds

Showing 20 of 100

About Blue Owl Capital

The firm's listing covers sectors FinTech, Healthcare, Real Estate and SaaS, and focus areas Biotech, Cybersecurity, Data Analytics and Direct Lending; known deals cluster at Growth, Late-Stage and Series A.

Of the 43 people on file at Blue Owl Capital, Soraya Kazziha (Managing Partner), Christopher Jensen (General Partner) and Marc Lipschultz (Chief Executive Officer) are listed as the contacts to approach first.

Across the known portfolio, 20 co-investors appear alongside Blue Owl Capital, including Neuberger Berman, Mirador Ventures and Ridgeback Capital.

Frequently asked questions

What is Blue Owl Capital?

Blue Owl Capital is a private equity firm and venture debt provider based in New York, United States, with a known portfolio of 10 companies. The portfolio comes from public investment records rather than from the firm, so deals that never surfaced publicly are not in it.

What does Blue Owl Capital invest in?

Listed sectors include FinTech, Healthcare, Real Estate and SaaS; listed focus areas include Biotech, Cybersecurity, Data Analytics and Direct Lending. Those tags come from the portfolio attached to the firm, so they describe what has been backed rather than a stated mandate for what comes next.

What stage does Blue Owl Capital invest at?

The known deals of Blue Owl Capital include Growth, Late-Stage and Series A rounds. Check that against your own round before reaching out: stage mismatch is the most common reason a well matched sector still goes nowhere.

Who should I pitch at Blue Owl Capital?

3 of the 43 people on file at Blue Owl Capital are listed as contacts for the firm. All 43 have their own profile page.

How do I contact Blue Owl Capital?

Any email address on file for the firm is masked on this page and readable inside RaiseHunt after you create an account. The 43 people attached to the firm have their own pages, each showing whether an address is on file for them.

Skip the browsing. Let AI find your ideal investors in one minute.

Paste your startup website and AI picks your best-fit investors out of 135,000+ profiles.

Data: RaiseHunt investor dataset · Snapshot 5 September 2026 · How this data is built · Report a correction or request removal